Skip to main content

Roche, Fluidigm Ink Deal to Co-market Access Array Platform with 454 Sequencing

Premium

By Justin Petrone

Fluidigm and Roche 454 Life Sciences this week announced that they have entered a worldwide co-promotional agreement that pairs Fluidigm's amplicon sample-preparation platform with Roche 454's high-throughput sequencers.

The partners will market Fluidigm’s Access Array System for use in target enrichment prior to sequencing on Roche 454's GS Junior or GS FLX System.

Launched last year, Access Array enables automated processing of 48 samples against 48 amplicons, resulting in PCR products that are ready for emPCR amplification. Amplicon sample preparation can take weeks using traditional approaches, the firms noted.

In addition to sequencing library preparation using amplicon tagging, the integrated fluidic circuit-based platform supports sample capture and target enrichment and sample barcoding for multiplexed sequencing, according to South San Francisco, Calif.-based Fluidigm.

454 CEO and President Christopher McLeod said the Access Array System and GS Junior are "extremely complementary," and enable the analysis of "large numbers of sample/amplicon combinations in an affordable workflow without the need for complicated liquid handling."

A single Access Array plate on a single GS Junior System run "generates as much data as hundreds, even thousands, of 96-well plates analyzed on a capillary sequencing system," McLeod said.

Financial terms of the deal were not discussed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.